Not provided
Not provided
Not provided
Not provided
Not provided
The tracker application has been withdrawn by developer and no other suitable tracker application has been identified to replace it.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this research study is to evaluate the impact of monitoring blood pressure from home everyday with pharmacist support.
High blood pressure is very common and increases risk of heart, kidney, brain, and eye disease. It is important to diagnose and treat high blood pressure to reduce risk of these complications. Getting blood pressure checked only when someone sees a doctor is not the best way to diagnose high blood pressure or to make sure blood pressure is well managed. Checking blood pressure at home gives a better idea of whether someone's blood pressure is normal or too high.
As part of their usual blood pressure monitoring, participants will be given an Omron 3 series or 5 series blood pressure monitor which has been cleared by the US Food and Drug Administration and validated to meet accuracy and performance requirements. For one month, participants will monitor their blood pressure once a day and then return the device to the clinic at the end of the study. Participants will text their blood pressure result to the American Heart Association's Check, Change, Control (CCC) secure online tracker.
As part of the research study, participants will also be randomized to either receive or not receive weekly check-in phone calls from a pharmacist to review their blood pressures and the number of times they tested in that week. Approximately 50 individuals will participate in this study. Participation in this study will last 1 month.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| With check-ins | Experimental | Daily blood pressure monitoring with weekly check-ins |
|
| Without check-ins | No Intervention | Daily blood pressure monitoring without weekly check-ins |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Weekly check-in | Behavioral | Weekly check-in phone calls from a pharmacist to review blood pressures and the number of times tested in that week |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in adherence to home blood pressure monitoring | Proportion of days blood pressure is measured based on data from the blood pressuring monitor | 1 month |
| Change in proportion of participants with a blood pressure <130/80 mm Hg. | Proportion of participants with a blood pressure <130/80 mm Hg. | 1 month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dave Dixon, PharmD | Virginia Commonwealth University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Virginia Commonwealth University | Richmond | Virginia | 23298 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided